Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

REGENERATE Study Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2184-2196
Number of pages13
JournalThe Lancet
Volume394
Issue number10215
DOIs
StatePublished - Dec 14 2019

ASJC Scopus Subject Areas

  • General Medicine

Cite this